š° Head To Study News
Head To Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Head To Study. Real-time updates on events, politics, business and more.
November 28, 2023
Novo Nordisk stock skidded Tuesday after Eli Lilly's weight-loss drug outperformed Novo's rival medication in a first-of-its-kind study. The post Lilly'sā¦
September 12, 2023
Risankizumab outperformed ustekinumab in rates of clinical remission at week 24 and rates of endoscopic remission at week 48, meeting both primary endpoints of the phase 3 trial.